Financing structure dynamics and other determinants of medicaid pharmaceutical expenditures, 1993-1996

Journal of Health Care Finance

Volumn 25, Issue 1, 1998, Pages 59-71

  Okunade, Albert A ^a,b  

^a UNIVERSITY OF MEMPHIS   (United States)

^b Memphis Leadership Found's C   (United States)

Author keywords

Medicaid managed care finance; OBRA90 (PL 101 508); OBRA93 (PL 103 213); Prescription drug expenditures; Veterans Health Act of 1992 (PL 102 585)

Indexed keywords

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE POLICY; HUMAN; MEDICAID; PRESCRIPTION; UNITED STATES;

BUDGETS; COST CONTROL; DRUG COSTS; HEALTH EXPENDITURES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MEDICAID; PRESCRIPTIONS, DRUG; STATE HEALTH PLANS; UNITED STATES;

EID: 0031691224     PISSN: 10786767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Colligen, B.H., ed. Pharmaceutical Benefits Under State Medical Assistance Programs. Reston, VA: National Pharmaceutical Council (Nov. 1994; 1996 and 1997 annual issues).
2. Okunade, A.A. "Do State-level Medicaid and Prison Expenditures Impact on Higher Education Appropriations?" Unpublished manuscript, The University of Memphis (1998).
3. Johnston, J.M. "The Medicaid Mandates of the 1980s: An Intergovernmental Perspective." Public Budgeting & Finance 17 (Spring 1997): 3-34.
4. Adams, E.K., and Gavin, N. "Patterns of Pharmacy Participation in Medicaid: Implementations for Enrollee Access." Inquiry 33 (Winter 1996/1997): 339-51.
5. Lichtenberg, F.R. "Do (More and Better) Drugs Keep People Out of Hospitals?" American Economic Review Papers & Proceedings 86 (May 1996): 384-88.
6. x Reimbursement Report." Drug Topics (Dec. 11, 1995, and Dec. 19, 1996 issues).
7. Okunade, A.A. "The Impact of 1990 Medicaid Drug Rebates Policy on Access to Prescription Drugs." (Invited) paper presented at the Southern Economic Association Annual Meetings, New Orleans, Louisiana. October 1995. Under publication review (1997).
8. Kotzan, J.A., Perri III, M., and Crosby, J.F. "An Economic Assessment of Implementing an Investment-Based Medicaid Reimbursement Policy." Journal of Research in Pharmaceutical Economics 6 (1995): 93-110.
9. Cohen, J.W., and Spector, W.D. "The Effect of Medicaid Reimbursement on Quality of Care in Nursing Homes." Journal of Health Economics 15 (1996): 23-48.
10. Ellis, R.P., and McGuire, T.G. "Supply-Side and Demand-Side Cost Sharing in Health Care." Journal of Economic Perspectives 7 (Fall 1993): 135-151.
11. Liebowitz, A. "The Demand for Prescription Drugs as a Function of Cost-Sharing." Social Science Medicine 21 (1985): 1,063-69.
12. McMillan, J.A., and Jankel, C.A. "Medicaid Drug Cost Containment: An Economic Perspective." Journal of Research in Pharmaceutical Economics 5 (1993): 69-87.
13. Rosenbaum, S. "A Look Inside Medicaid Managed Care." Health Affairs 16 (July/August 1997): 266-71.
14. Gabel, J. "Ten Ways HMOs Have Changed During the 1990s." Health Affairs 16 (May/ June 1997): 134-45.
15. Statistical Solutions. SOLARIS for Missing Data Analysis 1.0. Cork, Ireland: Statistical Solutions Ltd., 1997.
16. Pryor, D. " A Prescription for High Drug Prices." Health Affairs 9 (Fall 1990): 101-09.
17. Soumerai, S., et al. "Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing Homes." New England Journal of Medicine 325, no. 15 (10 October 1991): 1,072-77.